Literature DB >> 29426634

Model-based directional analysis of cardiovascular variability identifies patients developing atrial fibrillation after coronary artery bypass grafting.

Vlasta Bari1, Marco Ranucci1, Beatrice De Maria2, Beatrice Cairo3, Valeria Pistuddi1, Alberto Porta4.   

Abstract

BACKGROUND: Postoperative atrial fibrillation (AF) might be favored by cardiovascular control impairment. We hypothesize that cardiovascular regulation indexes derived from directional model-based analysis of the spontaneous fluctuations of heart period (HP) and systolic arterial pressure (SAP) can identify subjects at risk to develop AF after coronary artery bypass graft (CABG) surgery.
METHODS: Beat-to-beat HP and SAP series were derived from electrocardiogram (ECG) and invasive arterial pressure recorded for 5 min just before CABG surgery in conscious condition. The group comprised subjects who did develop AF (AF, n = 37, 71 ± 8 years, 27 males) or did not (noAF, n = 92, 65 ± 10 years, 85 males). From HP and SAP variabilities we computed classical time-domain, spectral, cross-spectral and complexity indexes characterizing autonomic function and cardiac baroreflex control. Moreover, we performed model-based directional analysis assessing the gain and strength of the relations from SAP to HP along cardiac baroreflex feedback and from HP to SAP along the feedforward pathway while disambiguating the effect of respiration as estimated from respiratory-related ECG modulations.
RESULTS: Classical HP and SAP variability indexes and baroreflex sensitivity could not separate AF from noAF individuals. Causality markers, and more specifically, the strength of the dynamical interactions from SAP to HP and vice versa, could distinguish the two groups: indeed, AFs have a lower degree of association from SAP to HP and vice versa.
CONCLUSIONS: An impairment of the feedforward and feedback arms of the HP-SAP closed loop relation predisposes subjects undergoing CABG surgery to develop postoperative AF. PERSPECTIVES: Competency in medical knowledge: Atrial fibrillation (AF) is a frequent complication after coronary artery bypass graft (CABG) surgery lengthening hospitalization duration and increasing healthcare system costs. Translational outlook 1: CABG patients who developed AF had a less preserved cardiovascular interactions due to less active physiological control mechanisms as resulting from the lower degree of dependence of systolic arterial pressure on heart period and vice versa before CABG surgery. Translational outlook 2: Cardiovascular control markers improve stratification of the AF risk after CABG surgery above and beyond more traditional demographic and clinical indexes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial pressure; Autonomic nervous system; Cardiac baroreflex; Cardiovascular control; Causality; Heart rate variability

Mesh:

Year:  2018        PMID: 29426634     DOI: 10.1016/j.ijcard.2018.01.071

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Comparison of Causal and Non-causal Strategies for the Assessment of Baroreflex Sensitivity in Predicting Acute Kidney Dysfunction After Coronary Artery Bypass Grafting.

Authors:  Vlasta Bari; Emanuele Vaini; Valeria Pistuddi; Angela Fantinato; Beatrice Cairo; Beatrice De Maria; Laura Adelaide Dalla Vecchia; Marco Ranucci; Alberto Porta
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

2.  Preoperative heart rate variability as a predictor of perioperative outcomes: a systematic review without meta-analysis.

Authors:  Mikkel Nicklas Frandsen; Jesper Mehlsen; Nicolai Bang Foss; Henrik Kehlet
Journal:  J Clin Monit Comput       Date:  2022-01-29       Impact factor: 1.977

3.  A retrospective study on atrial fibrillation after coronary artery bypass grafting surgery at The National Heart Institute, Kuala Lumpur.

Authors:  Ahmad Farouk Musa; Chou Zhao Quan; Low Zheng Xin; Trived Soni; Jeswant Dillon; Yuen Kah Hay; Rusli Bin Nordin
Journal:  F1000Res       Date:  2018-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.